Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPARγ/NF-κB/IL-6 signaling pathway

Traumatic brain injury (TBI) is the major cause of high mortality and disability rates worldwide. Pioglitazone is an activator of peroxisome proliferator-activated receptor-gamma (PPARγ) that can reduce inflammation following TBI. Clinically, neuroinflammation after TBI lacks effective treatment. Al...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Genes Dis
Hlavní autoři: Deng, Yongbing, Jiang, Xue, Deng, Xiaoyan, Chen, Hong, Xu, Jie, Zhang, Zhaosi, Liu, Geli, Yong, Zhu, Yuan, Chengfu, Sun, Xiaochuan, Wang, Changdong
Médium: Artigo
Jazyk:Inglês
Vydáno: Chongqing Medical University 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083749/
https://ncbi.nlm.nih.gov/pubmed/32215295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2019.05.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky